Dr. Sandor Batori, PhD

Dr. Sandor Batori, PhD

Skills in chemistry, drug discovery and medical writing
Europe (EU)
English, German, French, Russian
Academic affiliation

Organic chemist with long experience in drug discovery and development. Spent 20+ years in the big pharma world (Sanofi Ltd.). Experienced group leader, contributed to 5+ new drug developments. Honorary professor from the Technical University of Budapest.

Individual
Company

Skills

Lead optimization
Hit to lead
Team management (5-20 people)
ADMET
DMPK
Preclinical development
Patenting, IP, documentations
Inflammation
Structure-based drug design
Animal models
Structure registration

About

I have 17+ years in synthesis of heterocyclic compounds and study of their reactivities. This skill helped me in the drug discovery in industrial environment. I contributed to selection of 5+ drug candidates at Sanofi Ltd. and later I helped the successful drug development of 3 original drug candidates in the frame of different grants. I wrote IMPDs and IBs for clinical studies both for small molecules and protein-type drugs. The 10 years of experience as a coordinator of drug development grants helps me planning new projects regarding chemical synthesis, formulation, and ADME-T studies.

Work experience

Head of Medicinal Chemistry

Company:
AMRI Hungary
Duration:
Sep 2012
-
Apr 2013
present

Synthesis of new compounds for contract companies (lead optimization)

Different positions. Final: head of Discovery Chemistry

Company:
Sanofi/Chinoin Ltd
Duration:
Dec 1992
-
Aug 2012
present

Lead of Discovery chemistry; lead optimisation and selection of development candidate.

Chief worker

Company:
Central Research Institute for Chemistry, Hungarian Academy of Sciences
Duration:
Sep 1985
-
Nov 1992
present

Planning and performing of synthesis of chemical reactions and study of reactivity of new compounds

Education

Technical University Budapest

Degree:
Chemical engineer in drug research
Year of degree awarded:
1975

Publications

Case STUDIES

Development of MPH-220 Antispastic drug candidate.

Selection and characterization of the drug candidate.

Development of drug candidate SZV-1287 as neurophatic painkiller

Selection and characterization of the drug candidate and Phase I clinical study

Development of drug candidate Q134R-K for Alzheimer's disease

Selection and characterization of the drug candidate and Phase I clinical study